サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用生物製剤の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）
市場調査レポート
商品コード
1192940

動物用生物製剤の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）

Veterinary Biologics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
動物用生物製剤の世界市場 - 成長、将来の見通し、競合分析（2022年～2030年）
出版日: 2022年08月16日
発行: Acute Market Reports
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用生物製剤の市場規模は、2021年の219億5,380万米ドルから2030年までに368億3,650万米ドルに達し、2022年～2030年の予測期間中にCAGRで6.0％の成長が予測されています。人獣共通感染症の流行と、組み換えDNA技術によるワクチン製造の技術の発展が、市場成長を促進しています。

当レポートでは、世界の動物用生物製剤市場について調査分析し、市場力学、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 動物用生物製剤市場：競合分析

  • 主な動物用生物製剤市場ベンダーの市場ポジショニング
  • 動物用生物製剤市場ベンダーが採用する戦略
  • 主な業界戦略
  • 階層分析（2021年 vs. 2030年）

第4章 動物用生物製剤市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の動物用生物製剤の市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響の分析
  • シーソー分析

第5章 動物用生物製剤市場：製品別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：（2021年 vs. 2030年）
  • 市場セグメンテーション
    • ワクチン
    • 診断キット
    • 栄養とホルモンのサプリメント
    • アレルゲン抽出物
    • その他

第6章 動物用生物製剤市場：タイプ別（2020年～2030年）

  • 市場の概要
  • 成長と収益の分析：（2021年 vs. 2030年）
  • 市場セグメンテーション
    • 生産動物
    • コンパニオンアニマル

第7章 北米の動物用生物製剤市場（2020年～2030年）

  • 市場の概要
  • 動物用生物製剤市場：製品別（2020年～2030年）
  • 動物用生物製剤市場：タイプ別（2020年～2030年）
  • 動物用生物製剤市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合の動物用生物製剤市場（2020年～2030年）

  • 市場の概要
  • 動物用生物製剤市場：製品別（2020年～2030年）
  • 動物用生物製剤市場：タイプ別（2020年～2030年）
  • 動物用生物製剤市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋の動物用生物製剤市場（2020年～2030年）

  • 市場の概要
  • 動物用生物製剤市場：製品別（2020年～2030年）
  • 動物用生物製剤市場：タイプ別（2020年～2030年）
  • 動物用生物製剤市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカの動物用生物製剤市場（2020年～2030年）

  • 市場の概要
  • 動物用生物製剤市場：製品別（2020年～2030年）
  • 動物用生物製剤市場：タイプ別（2020年～2030年）
  • 動物用生物製剤市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカの動物用生物製剤市場（2020年～2030年）

  • 市場の概要
  • 動物用生物製剤市場：製品別（2020年～2030年）
  • 動物用生物製剤市場：タイプ別（2020年～2030年）
  • 動物用生物製剤市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • Boehringer Ingelheim Animal Health GmbH
  • Evonik Industries AG
  • Heska Corporation
  • Intetvet, Inc.
  • INDICAL Bioscience
  • IDEXX Laboratories, Inc.
  • Virbac, Inc.
  • VCA, Inc.
  • Zoetis
図表

List of Tables

  • TABLE 1 Global Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 3 North America Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 4 North America Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 5 U.S. Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 6 U.S. Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 7 Canada Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 8 Canada Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 13 UK Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 14 UK Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 15 Germany Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 16 Germany Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 17 Spain Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Spain Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 19 Italy Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 20 Italy Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 21 France Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 22 France Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 25 Asia Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 26 Asia Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 27 China Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 28 China Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 29 Japan Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Japan Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 31 India Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 32 India Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 33 Australia Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Australia Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 35 South Korea Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 36 South Korea Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 37 Latin America Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Latin America Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 39 Brazil Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 40 Brazil Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 41 Mexico Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 42 Mexico Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 47 GCC Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 48 GCC Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 49 Africa Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Africa Veterinary Biologics Market By Type, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Veterinary Biologics Market By Product, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Veterinary Biologics Market By Type, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Veterinary Biologics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Veterinary Biologics Market: Quality Assurance
  • FIG. 5 Global Veterinary Biologics Market, By Product, 2021
  • FIG. 6 Global Veterinary Biologics Market, By Type, 2021
  • FIG. 7 Global Veterinary Biologics Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Veterinary Biologics Market, 2021
  • FIG. 9 Market Positioning of Key Veterinary Biologics Market Players, 2021
  • FIG. 10 Global Veterinary Biologics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Veterinary Biologics Market, By Product, 2021 Vs 2030, %
  • FIG. 12 Global Veterinary Biologics Market, By Type, 2021 Vs 2030, %
  • FIG. 13 U.S. Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 20 France Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 22 China Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 24 India Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Veterinary Biologics Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Veterinary Biologics Market (US$ Million), 2020 - 2030
目次
Product Code: 138552-08-22

The veterinary biologics market is set to reach from US$ 21,953.8 Mn in 2021 to US$ 36,836.5 Mn by 2030 at a compound annual growth rate (CAGR) of 6.0% during the forecast period from 2022 to 2030. Veterinary biologics are medicinal products obtained from living organism and biological processes. They are employed in veterinary health science to diagnose, prevent and treat animal disease through immune-modulation. According to United States Department of Agriculture (USDA), over the span of 70 years there has been a significant growth in the veterinary biologics market, wherein today approximately 2000 licensed biological products are employed to treat 200 different types of disease in 35 animal species.

"Rising prevalence of zoonotic diseases and technological development in vaccine production by recombinant DNA technology drive the vaccines market growth"

Vaccines are currently leading the product segment for veterinary biologics market. The major factors contributing to its culminating growth are rising prevalence of zoonotic disease and technological innovation in veterinary vaccines production employing the recombinant DNA technology. Molecular diagnostic kits holds the second largest market in the products segment on account of increasing prevalence of contagious disease in poultry, bovine and porcine animal species. Nutritional and hormonal supplement will be the fastest growing market on account of increasing demand for dairy and meat industry and growing important of probiotics to improve animal feed products quality.

"Proactive government policies focusing on long term sustainable development and improving livestock health drive the production animal market growth"

Currently production animals are reigning the animal type segment pertaining to veterinary biologics market. Proactive government policies throughout the globe are focusing on long term sustainable growth by ensuring total food security and improving livestock healthcare. According to the research findings of Food and Agriculture Organization (FAO), animal based food products accounts for one third of human protein consumption. Rampant growth in dairy industry further propels the production animal market growth. Companion animals will be the fastest growing animal type segment in the near future due to significant growth in pet adoption and stringent government norms for mandatory vaccination of pet animals.

"Existence of highly developed agrobased industry and rampant growth in animal husbandry department drive the market growth in North America"

In the present scenario North America accounts for 40% of the global market share in veterinary biologics market. The key factors responsible for the dominance of North America are presence of highly developed agrobased industry and rapid growth in animal husbandry department. Rising public animal health awareness and significant growth in pet adoption further fortify the veterinary biologics market growth in North America. Europe represents 31% market share and is the second largest regional segment for veterinary biologics market. Increasing growth in dairy and meat industry and stringent regulatory norms imposed by healthcare agencies for compulsory vaccination of animals propels the market growth in European region. Asia Pacific holds 17% market share and will be the fastest growing market during the forecast period from 2022 to 2030. Rising prevalence of zoonotic disease and proactive government policies to financially support veterinary departments consolidate the veterinary biologics market growth in Asia Pacific region. Latin America and Middle East & Africa serve as a potential market for major players to promote business expansion and capture the untapped market in rural areas.

Biopharmaceutical companies actively participating in veterinary biologics market are Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc. and Zoetis.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Veterinary Biologics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Veterinary Biologics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Vaccines

Diagnostic Kits

Nutritional and Hormonal Supplement

Allergenic Extract

Others

Type

Production Animal

Companion Animal

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Veterinary Biologics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Veterinary Biologics market?

Which is the largest regional market for Veterinary Biologics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Veterinary Biologics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Veterinary Biologics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Veterinary Biologics Market
  • 2.2. Global Veterinary Biologics Market, By Product, 2021 (US$ Million)
  • 2.3. Global Veterinary Biologics Market, By Type, 2021 (US$ Million)
  • 2.4. Global Veterinary Biologics Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Veterinary Biologics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Veterinary Biologics Market Vendors
  • 3.2. Strategies Adopted by Veterinary Biologics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Veterinary Biologics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Veterinary Biologics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Vaccines
    • 5.3.2. Diagnostic Kits
    • 5.3.3. Nutritional and Hormonal Supplement
    • 5.3.4. Allergenic Extract
    • 5.3.5. Others

6. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Production Animal
    • 6.3.2. Companion Animal

7. North America Veterinary Biologics Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
  • 7.3. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
  • 7.4.Veterinary Biologics Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.1.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.2.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 7.4.1.3.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

8. UK and European Union Veterinary Biologics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
  • 8.3. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
  • 8.4.Veterinary Biologics Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.1.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.2.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.3.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.4.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.5.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 8.4.1.6.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

9. Asia Pacific Veterinary Biologics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
  • 9.3. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
  • 9.4.Veterinary Biologics Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.1.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.2.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.3.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.4.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.5.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 9.4.1.6.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

10. Latin America Veterinary Biologics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
  • 10.3. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
  • 10.4.Veterinary Biologics Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.1.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.2.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 10.4.1.3.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

11. Middle East and Africa Veterinary Biologics Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
  • 11.3. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
  • 11.4.Veterinary Biologics Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.1.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.2.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Veterinary Biologics Market: By Product, 2020-2030, USD (Million)
        • 11.4.1.3.1. Veterinary Biologics Market: By Type, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Boehringer Ingelheim Animal Health GmbH
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Boehringer Ingelheim Animal Health GmbH
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Evonik Industries AG
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Heska Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Intetvet, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. INDICAL Bioscience
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. IDEXX Laboratories, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Virbac, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. VCA, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Zoetis
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives